$FIG

Herb Tyler sold $40K of FIG

Herb Tyler (Chief Accounting Officer) sold 1,536 shares of Figma, Inc. (FIG) at $26.00 on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Herb Tyler
Published Aug 4, 2026, 11:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 11:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FIG
Neutral
medium confidence
Mentioned
$FIG
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FIGNeutralLow
01

Why it matters

The newest fact is the specific sale details: 1,536 shares at $26.00 for about $39,936, executed 2026-08-03 and filed 2026-08-04, with a stated pre-arranged 10b5-1 plan.

02

Market read

Primarily a sentiment/positioning datapoint; it does not provide new operational, financial, or regulatory information about Figma.

03

What to watch

Traders may focus on the sale size, but the disclosure lacks context on total holdings, diversification needs, or whether other insiders are buying/selling around the same period.

Relevance 2/10Novelty 3/10Timing: filed 2026-08-04 after-hours; sale executed 2026-08-03

Background

The article is an SEC Form 4 insider transaction disclosure for Figma, Inc., reported by Chief Accounting Officer Herb Tyler.

Company-level read

Ticker impact

$FIGNeutralMedium confidence
Context

Figma Form 4 shows CFO Herb Tyler sold 1,536 shares at $26.00 on 2026-08-03 under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

Minimal; insider sale does not change broader SaaS or design-software fundamentals.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Figma, Inc.

    Subject of the Form 4 insider transaction disclosure (FIG).

  • Herb Tyler

    Chief Accounting Officer who sold shares under a pre-arranged 10b5-1 plan.

Related articles

$FIGMedAI 8/10

Figma Q2 Earnings Call Highlights

Figma’s Q2 earnings call highlighted higher AI inference costs affecting operating income and free cash flow. For Q3, it forecast revenue of $373M to $375M (36% growth at midpoint). It raised full-year revenue outlook by $40M to $1.463B to $1.467B and kept non-GAAP operating income at $125M to $135M. Figma said AI credit consumption and agent adoption drove results.

$FIGHighAI 9/10

Why Figma Stock Just Sank

Figma, Inc. shares fell about 14.9% Thursday after results. The company reported Q2 revenue up 48% to just over $370M, above the $351.5M estimate, and adjusted EPS of $0.08. However, cost of revenue rose 117%, driven largely by AI infrastructure and hosting. Q3 revenue guidance was $373M to $375M. CEO Dylan Field said the CMO and CPO will leave.

$DDOGMed

Software stocks sink, led by declines from Figma, Datadog

Software stocks fell Thursday after quarterly results from Datadog, Figma, and HubSpot. Datadog shares dropped more than 15% despite beating revenue and earnings; adjusted gross margin was 80% versus 80.7% consensus. Figma also fell after warning of higher AI inference spending. iShares Expanded Tech-Software ETF (IGV) fell over 2%.

$SNDKMed

Futures Flat As Tech Slides After Memory Stocks, Korea Tumble

US stock index futures were mixed, with S&P futures up 0.1% and Nasdaq futures down 0.5% as Sandisk (SNDK) fell about 9% and Western Digital (WDC) about 15% after earnings and weaker memory outlooks. Tech and AI names also dropped on results or guidance misses, while Mag 7 were mixed. Asian markets declined after chip-related losses, and investors awaited US payrolls.